Obesity Pharmacotherapy: Tirzepatide, Semaglutide, Phentermine-Topiramate
Obesity is now recognized as a chronic relapsing disease, and modern pharmacotherapy has reached efficacy approaching bariatric surgical outcomes. The most effective single agent is tirzepatide (GIP/GLP-1 dual agonist), achieving approximately 22 percent weight loss at 72 weeks in SURMOUNT-1.